Entity

GLP-1

GLP-1 — glucagon-like peptide-1 (agonists). The drug class behind Ozempic and Wegovy — obesity and diabetes treatments reshaping pharma pipelines and food-industry forecasts.

As of 5 Nov 2026Last evidence 4 Nov 2026

What is happening now

Nothing reported: the record holds no registered event and no claim that names this.

What changed

  • Attention Fading: 37 mentions on 5 Nov 2026, against 40 on 15 Oct 2026 (-8%).
  • State No change in coverage state or wire tier recorded since 28 Oct 2026.
  • Claims No claim first reported since 4 Nov 2026.

How well we know this

618 documents · 143 publishers · 8% contain a typed assertion · last evidence 4 Nov 2026

  • Gap: assertion coverage 0.079: about 92% of mentions carry no typed assertion
  • Gap: 1 receipt withheld: no source link (the same rule the topic record applies)

In this snapshot’s daily coverage:

Reported alongside GLP-1

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

FDAEli LillyAIChina
  • Weight Loss · 225 shared documents · no page of its own yet
  • FDA · 156 shared documents
  • Glp-1s · 145 shared documents · no page of its own yet
  • Eli Lilly · 141 shared documents
  • AI · 112 shared documents
  • Novo Nordisk · 90 shared documents · no page of its own yet
  • Mounjaro · 83 shared documents · no page of its own yet
  • China · 77 shared documents
  • Buy · 73 shared documents · no page of its own yet
  • Clinical Trials · 71 shared documents · no page of its own yet

Story momentum

Fading

The word compares 37 mentions on 5 Nov 2026 with 40 on 15 Oct 2026 (-8%); a change of less than 8% either way reads Steady.

Daily mentions +363% from 21 Sept 2026 to 5 Nov 2026, between 5 and 51 a day

How often tracked coverage mentions GLP-1, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about GLP-1 yet. Ask about GLP-1

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/6d911ae375a0bffac4f2f4c7 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name glp-1.

{
  "name": "glp-1",
  "label": "GLP-1",
  "asOf": "2026-11-05",
  "mentions": 92,
  "outlets": 43,
  "domains": 15,
  "node": {
    "id": "sb:e/6d911ae375a0bffac4f2f4c7",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/6d911ae375a0bffac4f2f4c7",
    "knowledgeCutoff": "2026-11-05T23:35:16.585296+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "fading",
  "history": {
    "since": "2026-10-28T13:09:07.865030+00:00",
    "changes": 0
  },
  "whereFrom": {
    "level": "counts",
    "label": "92 mentions across 15 domains",
    "children": [
      {
        "level": "reports",
        "label": "5 reports drawn on this page, each with its link",
        "children": {
          "count": 5,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "15 coverage domains",
        "children": {
          "count": 15,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 87 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving GLP-1

Nothing reported: the record holds no registered event and no claim that names this.

Walk the record from GLP-1

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

GLP-1

Entity.

Evidence
618 documents · 143 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 Apr 2026, last seen 4 Nov 2026
Measured
8% of mentions say something specific about it; the rest only name it
As of
5 Nov 2026
10 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (0)

none on file at this cutoff

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names GLP-1, newest first. Open any row to follow it to the original article.

1 more headline counted but not shown: no source link on file

Evidence tiers: primary source = an official public record · attributed = a named outlet, receipt linked · lead = observed, not yet receipted.

What it connects to

Related records.

Pull a thread

Recorded history

No change in coverage state or wire tier recorded since 28 Oct 2026.

Ask about GLP-1Watch GLP-1

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 5 Nov 2026.